Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GRMN✓SelectedUSD · GRMNGSK vs GRMN performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs GRMN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
GRMN return
+109.2%
Excess return
-68.1%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGRMNExcessAlpha
1D-0.1%-1.4%+1.3%0.0%
7D-5.3%-5.3%0.0%-4.9%
30D-3.7%-7.9%+4.3%-3.1%
3M-7.3%-8.2%+0.9%-6.7%
6M-4.2%+13.8%-18.1%-5.2%
YTD+0.9%+33.7%-32.9%-1.2%
1Y+7.3%+45.6%-38.4%+4.6%
3Y+52.7%+135.0%-82.2%+37.4%
All+41.1%+109.2%-68.1%+30.1%

Cumulative growth

Daily Returns

Daily percentage return beside GRMN.

Daily Out/Under-Performance

Portfolio return minus GRMN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GRMN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling